Rating History for Genmab A/S (GMAB) by Wells Fargo

Date Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
3/2/2026 Eva Fortea Verdejo New Coverage Overweight
(N/A)
40.00
(N/A)
29.44
(27.06)
-8.08% Details